Mercury Systems to Present at the Cowen and Company 37th Annual Aerospace/Defense Conference
Jan 27, 2016 21:15 pm UTC| Business
CHELMSFORD, Mass., Jan. 27, 2016 -- Mercury Systems, Inc. (NASDAQ:MRCY) (www.mrcy.com), announced that it will participate in the Cowen and Company 37th Annual Aerospace/Defense Conference to be held February 3-4, 2016,...
Artesian Resources Corporation Declares Common Stock Dividend
Jan 27, 2016 21:09 pm UTC| Business
NEWARK, Del., Jan. 27, 2016 -- Artesian Resources Corporation (NASDAQ:ARTNA) announced today that its Board of Directors has declared a regular quarterly dividend on the company’s Class A and Class B Common Stock. The...
AbCellera and Merck Sign Novel Therapeutic Antibody Discovery Collaboration
Jan 27, 2016 21:08 pm UTC| Business
VANCOUVER, British Columbia, Jan. 27, 2016 -- AbCellera, a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune cells, today announced a new collaboration with Merck,...
First Connecticut Bancorp, Inc. Reports Fourth Quarter 2015 Earnings of $0.16 Earnings Per Share
Jan 27, 2016 21:05 pm UTC| Business
FARMINGTON, Conn., Jan. 27, 2016 -- First Connecticut Bancorp, Inc. (the “Company”) (NASDAQ:FBNK), the holding company for Farmington Bank (the “Bank”), reported net income of $2.4 million, or $0.16 diluted earnings per...
Jan 27, 2016 21:05 pm UTC| Business
Preliminary Revenue Grew 34% to $172.5 millionExpected to Achieve Fiscal Year 2015 Guidance across All MetricsIntroduces Fiscal Year 2016 Guidance SOUTHFIELD, Mich., Jan. 27, 2016 -- Diversified Restaurant Holdings,...
Datawatch Announces First Quarter 2016 Financial Results
Jan 27, 2016 21:05 pm UTC| Business
BEDFORD, Mass., Jan. 27, 2016 -- Datawatch Corporation (NASDAQ-CM:DWCH), a leading global provider of self-service data preparation and visual analytics solutions, today announced that total revenue for its first...
TRACON Pharmaceuticals Announces Initiation of TRC102 Phase 2 Clinical Trial in Glioblastoma
Jan 27, 2016 21:05 pm UTC| Business
SAN DIEGO, Jan. 27, 2016 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age‐related...